NASDAQ: HSTM
Healthstream Inc Stock Forecast, Predictions & Price Target

Analyst price target for HSTM

Based on 1 analyst offering 12 month price targets for Healthstream Inc

Min Forecast
$28.00+37.66%
Avg Forecast
$28.00+37.66%
Max Forecast
$28.00+37.66%

Should I buy or sell HSTM stock?

Based on 1 analyst offering ratings for Healthstream Inc.

Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model agrees with analyst consensus with a "Hold" rating. Learn More

Be the first to know when Wall Street analysts revise their HSTM stock forecasts and price targets.

HSTM stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-12-17

1 of 1

Forecast return on equity

Is HSTM forecast to generate an efficient return?

Company
N/A
Industry
23.61%
Market
181.01%

Forecast return on assets

Is HSTM forecast to generate an efficient return on assets?

Company
N/A
Industry
18.11%

HSTM earnings per share forecast

What is HSTM's earnings per share in the next 2 years based on estimates from 7 analysts?

Avg 1 year Forecast
$0.77+25.41%
Avg 2 year Forecast
$0.88+43.8%
HSTM's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

HSTM revenue forecast

What is HSTM's revenue in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
$332.8M+9.45%
Avg 2 year Forecast
$349.9M+15.06%
Avg 3 year Forecast
$346.7M+14.04%
HSTM's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

HSTM earnings growth forecast

How is HSTM forecast to perform vs Health Information Services companies and vs the US market?

Company
17.49%
Industry
28.31%
Market
36.08%
HSTM's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
HSTM's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
HSTM's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

HSTM revenue growth forecast

How is HSTM forecast to perform vs Health Information Services companies and vs the US market?

Company
5.12%
Industry
9.09%
Market
13.32%
HSTM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
HSTM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

HSTM vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
HSTM$20.34$28.00+37.66%Hold
NUTX$88.99N/AN/A
GDRX$2.03$3.81+87.49%Buy
PHR$11.86$28.91+143.75%Strong Buy
OMDA$13.51$23.38+73.02%Strong Buy

Healthstream Stock Forecast FAQ

Is Healthstream Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: HSTM) stock is to Hold HSTM stock.

Out of 1 analyst, 0 (0%) are recommending HSTM as a Strong Buy, 0 (0%) are recommending HSTM as a Buy, 1 (100%) are recommending HSTM as a Hold, 0 (0%) are recommending HSTM as a Sell, and 0 (0%) are recommending HSTM as a Strong Sell.

If you're new to stock investing, here's how to buy Healthstream stock.

What is HSTM's earnings growth forecast for 2026-2027?

(NASDAQ: HSTM) Healthstream's forecast annual earnings growth rate of 17.49% is not forecast to beat the US Health Information Services industry's average forecast earnings growth rate of 28.31%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 36.08%.

Healthstream's earnings in 2026 is $18,342,000.On average, 7 Wall Street analysts forecast HSTM's earnings for 2026 to be $22,457,608, with the lowest HSTM earnings forecast at $20,713,841, and the highest HSTM earnings forecast at $24,042,851.

In 2027, HSTM is forecast to generate $25,751,390 in earnings, with the lowest earnings forecast at $23,015,378 and the highest earnings forecast at $30,515,926.

What is HSTM's revenue growth forecast for 2026-2028?

(NASDAQ: HSTM) Healthstream's forecast annual revenue growth rate of 5.12% is not forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 9.09%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.32%.

Healthstream's revenue in 2026 is $304,064,000.On average, 7 Wall Street analysts forecast HSTM's revenue for 2026 to be $9,770,086,844, with the lowest HSTM revenue forecast at $9,341,190,570, and the highest HSTM revenue forecast at $10,135,573,401. On average, 7 Wall Street analysts forecast HSTM's revenue for 2027 to be $10,270,319,048, with the lowest HSTM revenue forecast at $9,767,151,209, and the highest HSTM revenue forecast at $10,653,419,415.

In 2028, HSTM is forecast to generate $10,179,020,799 in revenue, with the lowest revenue forecast at $9,779,774,439 and the highest revenue forecast at $10,478,455,569.

What is HSTM's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: HSTM) forecast ROA is N/A, which is lower than the forecast US Health Information Services industry average of 18.11%.

What is HSTM's Price Target?

According to 1 Wall Street analyst that have issued a 1 year HSTM price target, the average HSTM price target is $28.00, with the highest HSTM stock price forecast at $28.00 and the lowest HSTM stock price forecast at $28.00.

The Wall Street analyst predicted that Healthstream's share price could reach $28.00 by Dec 17, 2026. The average Healthstream stock price prediction forecasts a potential upside of 37.66% from the current HSTM share price of $20.34.

What is HSTM's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: HSTM) Healthstream's current Earnings Per Share (EPS) is $0.61. On average, analysts forecast that HSTM's EPS will be $0.77 for 2026, with the lowest EPS forecast at $0.71, and the highest EPS forecast at $0.82. In 2027, HSTM's EPS is forecast to hit $0.88 (min: $0.78, max: $1.04).

What is HSTM's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: HSTM) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.